SCHEMBL219617

SCHEMBL219617

[CH2]CCCOCC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8468107 0.97 MEN1 (0.30)
SCHEMBL51000 0.93
SCHEMBL220749 0.89 MEN1 (0.32)
SCHEMBL3683039 0.89 TSHR (0.30)
SCHEMBL3682811 0.89 MEN1 (0.32)
SCHEMBL3673825 0.89 TSHR (0.30)
SCHEMBL7620160 0.87
SCHEMBL9148014 0.87 MEN1 (0.33)
SCHEMBL9124662 0.86 MEN1 (0.31)
SCHEMBL15435869 0.86 MEN1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395459-A1 THERMOSETTING RESIN COMPOSITION AND METHOD FOR MANUFACTURING SAME SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) 2021-12-23 US disclosed
US-9072791-B2 Photostabilized pharmaceutical compositions DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2015-07-07 US disclosed
US-8088916-B2 Hyaluronic acid-methotrexate conjugate DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2012-01-03 US disclosed
US-20110245276-A1 PHOTOSTABILIZED PHARMACEUTICAL COMPOSITIONS DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed
EP-2343078-A1 LIGHT-STABILIZED PHARMACEUTICAL COMPOSITION DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2011-07-13 EP disclosed
US-7807675-B2 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2010-10-05 US disclosed
US-20090093414-A1 Hyaluronic Acid-Methotrexate Conjugate DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 2009-04-09 US disclosed
US-20080014288-A1 Zinc-containing treatments for hyperphosphatemia GENZYME CORPORATION 2008-01-17 US disclosed
EP-1830832-A1 ZINC-CONTAINING TREATMENTS FOR HYPERPHOSPHATEMIA Genzyme Corporation (US) 2007-09-12 EP disclosed
US-20070197465-A1 Hyaluronic Acid-Methotrexate Conjugate DENKI KAGAKU KABUSHIKI KAISHA (JP) 2007-08-23 US disclosed
US-5461051-A Tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use SANKYO COMPANY, LIMITED (JP) 1995-10-24 US disclosed
EP-0648827-A1 Reactive liquid crystal compounds MERCK PATENT GmbH (DE) 1995-04-19 EP disclosed
US-5362725-A Antiallergens, antiasthmatic SANKYO COMPANY, LIMITED (JP) 1994-11-08 US disclosed
EP-0615630-A1 LIQUID CRYSTALLINE MATERIAL MERCK PATENT GmbH (DE) 1994-09-21 EP disclosed
WO-1994008268-A1 LIQUID CRYSTALLINE MATERIAL MERCK PATENT GMBH (DE) 1994-04-14 WO disclosed
EP-0591508-A1 ELECTROOPTICAL LIQUID CRYSTAL SYSTEM MERCK PATENT GmbH (DE) 1994-04-13 EP disclosed
WO-1993022397-A1 ELECTROOPTICAL LIQUID CRYSTAL SYSTEM MERCK PATENT GMBH (DE) 1993-11-11 WO disclosed
EP-0505014-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1992-09-23 EP disclosed
EP-0421823-A2 Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use Sankyo Company Limited (JP) 1991-04-10 EP disclosed
US-4059581-A Heterocyclic nitrogen containing siloxanes UNION CARBIDE CORPORATION (US) 1977-11-22 US disclosed